Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats

[1]  N. Gueven,et al.  Alzheimer's Disease and NQO1: Is there a Link? , 2017, Current Alzheimer research.

[2]  S. Bachurin,et al.  Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends , 2017, Medicinal research reviews.

[3]  Jeong-An Gim,et al.  Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives. , 2017, Gene.

[4]  C. Pike.  Sex and the development of Alzheimer's disease , 2017, Journal of neuroscience research.

[5]  M. Díaz-Hung,et al.  Beta Amyloid Peptides: Extracellular and Intracellular Mechanisms of Clearance in Alzheimer’s Disease , 2016 .

[6]  L. Berumen,et al.  Therapies for Prevention and Treatment of Alzheimer's Disease , 2016, BioMed research international.

[7]  Jie Yu,et al.  Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro , 2016, Marine drugs.

[8]  Won-Kyung Cho,et al.  Fermented Sipjeondaebo-tang Alleviates Memory Deficits and Loss of Hippocampal Neurogenesis in Scopolamine-induced Amnesia in Mice , 2016, Scientific Reports.

[9]  Qing-Zhi He,et al.  PFOS Disturbs BDNF-ERK-CREB Signalling in Association with Increased MicroRNA-22 in SH-SY5Y Cells , 2015, BioMed research international.

[10]  Jeong Hee Kim,et al.  Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer’s Disease , 2015, PloS one.

[11]  Manzoor Ahmad Sofi,et al.  Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  K. Ashe,et al.  Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment. , 2015, Journal of visualized experiments : JoVE.

[13]  M. Xue,et al.  The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease , 2015, Oxidative medicine and cellular longevity.

[14]  A. Saravanakumar,et al.  Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model , 2015, Scientific Reports.

[15]  S. Linse,et al.  Fluorescent Filter-Trap Assay for Amyloid Fibril Formation Kinetics in Complex Solutions , 2015, ACS chemical neuroscience.

[16]  S. Hooshmand,et al.  Dietary phosphorus exacerbates bone loss induced by cadmium in ovariectomized rats , 2014, Menopause.

[17]  Mehdi Farhoudi,et al.  Amyloid-Beta: A Crucial Factor in Alzheimer's Disease , 2014, Medical Principles and Practice.

[18]  Bombi Lee,et al.  Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats , 2014, BMC Complementary and Alternative Medicine.

[19]  A. Boguszewska-Czubara,et al.  Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice , 2014, Psychopharmacology.

[20]  M. Boccia,et al.  Neuropharmacology of memory consolidation and reconsolidation: Insights on central cholinergic mechanisms , 2014, Journal of Physiology-Paris.

[21]  A. A. Abdel Moneim,et al.  Neuroprotective effects of Citrus reticulata in scopolamine-induced dementia oxidative stress in rats. , 2014, CNS & neurological disorders drug targets.

[22]  R. Mayeux,et al.  Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers , 2014 .

[23]  V. Andrisano,et al.  From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease , 2014, Pharmacology research & perspectives.

[24]  A. Mietelska-Porowska,et al.  Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction , 2014, International journal of molecular sciences.

[25]  M. C. P. Batitucci,et al.  Antimutagenic activity of ipriflavone against the DNA-damage induced by cyclophosphamide in mice. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  Jinzhong Chen,et al.  Lycium barbarum Polysaccharides Prevent Memory and Neurogenesis Impairments in Scopolamine-Treated Rats , 2014, PloS one.

[27]  I. Hong,et al.  Anti-Oxidative Effects of Rooibos Tea (Aspalathus linearis) on Immobilization-Induced Oxidative Stress in Rat Brain , 2014, PloS one.

[28]  Torbjörn Persson,et al.  Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail? , 2014, Oxidative medicine and cellular longevity.

[29]  Jun Wu,et al.  The neuroprotective effects of ipriflavone against H ₂O ₂ and amyloid beta induced toxicity in human neuroblastoma SH-SY5Y cells. , 2013, European journal of pharmacology.

[30]  A. Hamed,et al.  In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer disease , 2013, BMC Complementary and Alternative Medicine.

[31]  Marguerite Prior,et al.  The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice , 2013, Alzheimer's Research & Therapy.

[32]  Rena Li,et al.  Estrogen synthesis and signaling pathways during aging: from periphery to brain. , 2013, Trends in molecular medicine.

[33]  Yinghe Hu,et al.  Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration , 2012, Translational Neurodegeneration.

[34]  N. Delibaş,et al.  Effects of chronic scopolamine administration on spatial working memory and hippocampal receptors related to learning , 2012, Behavioural pharmacology.

[35]  S. W. Bihaqi,et al.  Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (AβPP) expression in rat brain , 2012, Indian journal of pharmacology.

[36]  I. Shim,et al.  Phellodendron amurense and Its Major Alkaloid Compound, Berberine Ameliorates Scopolamine-Induced Neuronal Impairment and Memory Dysfunction in Rats , 2012, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[37]  M. Tabaton,et al.  Amyloid-β Production: Major Link Between Oxidative Stress and BACE1 , 2012, Neurotoxicity Research.

[38]  I. P. Aranha,et al.  Mutagenicity of ipriflavone in vivo and in vitro. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[39]  N. Ip,et al.  Cdk5: a multifaceted kinase in neurodegenerative diseases. , 2012, Trends in cell biology.

[40]  K. Wesnes,et al.  The scopolamine model as a pharmacodynamic marker in early drug development , 2012, Psychopharmacology.

[41]  A. Dwivedi,et al.  Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study. , 2012, Journal of ethnopharmacology.

[42]  F. Wu,et al.  Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells , 2011, BMC Neuroscience.

[43]  A. Melo,et al.  Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives , 2011, Oxidative medicine and cellular longevity.

[44]  M. Thakur,et al.  Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells , 2011, PLoS ONE.

[45]  M. Bajda,et al.  Multi-target-directed ligands in Alzheimer's disease treatment. , 2011, Current medicinal chemistry.

[46]  Thomas L. Williams,et al.  Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.

[47]  J. Simpkins,et al.  The assessment of non-feminizing estrogens for use in neuroprotection , 2011, Brain Research.

[48]  W. Bao,et al.  Memory impairment in cognitively impaired aged rats associated with decreased hippocampal CREB phosphorylation: reversal by procyanidins extracted from the lotus seedpod. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[49]  Mark P Mattson,et al.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. , 2010, Biochimica et biophysica acta.

[50]  G. Gillies,et al.  Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines , 2010, Pharmacological Reviews.

[51]  S. Mengi,et al.  Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats , 2010, Indian journal of pharmacology.

[52]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[53]  I. Shim,et al.  Effect of wild ginseng on scopolamine‐induced acetylcholine depletion in the rat hippocampus , 2010, The Journal of pharmacy and pharmacology.

[54]  M. Tabaton,et al.  JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1 , 2009, Neurobiology of Aging.

[55]  P. Wise,et al.  Estradiol: a hormone with diverse and contradictory neuroprotective actions , 2009, Dialogues in clinical neuroscience.

[56]  C. Pike,et al.  Protective actions of sex steroid hormones in Alzheimer’s disease , 2009, Frontiers in Neuroendocrinology.

[57]  E. Peskind,et al.  S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10 , 2009, PloS one.

[58]  J. Simpkins,et al.  Review: The potential for estrogens in preventing Alzheimer's disease and vascular dementia , 2009, Therapeutic advances in neurological disorders.

[59]  Piero Antuono,et al.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.

[60]  N. Belyaev,et al.  Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease. , 2008, Current Alzheimer research.

[61]  R. Agrawal,et al.  Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. , 2008, European journal of pharmacology.

[62]  Jie Xu,et al.  Effects of Phytoestrogen on Mitochondrial Structure and Function of Hippocampal CA1 Region of Ovariectomized Rats , 2008, Cellular and Molecular Neurobiology.

[63]  John Woulfe,et al.  Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production , 2008, Neurobiology of Disease.

[64]  A. Granholm,et al.  Patterns of Neurotrophin Protein Levels in Male and Female Fischer 344 Rats from Adulthood to Senescence: How Young is “Young” and How Old is “Old”? , 2007, Experimental aging research.

[65]  D. Butterfield,et al.  Natural antioxidants in Alzheimer's disease , 2007, Expert opinion on investigational drugs.

[66]  Roberto Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .

[67]  Kaia Palm,et al.  Mouse and rat BDNF gene structure and expression revisited , 2006, Journal of neuroscience research.

[68]  Ana Martínez,et al.  Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. , 2006, Current pharmaceutical design.

[69]  J. Morrison,et al.  Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women , 2006, The Journal of Neuroscience.

[70]  M. Rao,et al.  Studies on the quantitative and qualitative characters of cocoons and silk from methoprene and fenoxycarb treated Bombyx mori (L) larvae , 2006 .

[71]  K. Korach,et al.  Estrogen receptors and human disease. , 2006, The Journal of clinical investigation.

[72]  M. Luca,et al.  Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients , 2005, Neurobiology of Disease.

[73]  J. Simpkins,et al.  Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo , 2005, Brain Research.

[74]  N. Nalivaeva,et al.  Targeting Amyloid‐Degrading Enzymes as Therapeutic Strategies in Neurodegeneration , 2004, Annals of the New York Academy of Sciences.

[75]  B. Wolozin,et al.  Cholesterol and the Biology of Alzheimer's Disease , 2004, Neuron.

[76]  A. Attia,et al.  Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine , 2003, Pharmacology Biochemistry and Behavior.

[77]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[78]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Collins,et al.  Antioxidant efficacy of phytoestrogens in chemical and biological model systems. , 1998, Archives of biochemistry and biophysics.

[80]  A. Svanborg,et al.  The ovarian hormone deficiency-induced hypercholesterolemia is reversed by soy protein and the synthetic isoflavone, ipriflavone , 1997 .

[81]  B. Arjmandi,et al.  Effects of Ovariectomy, Estrogen, and Ipriflavone on Liver Lipids and Cholesterol in a Rat Model , 1995 .

[82]  Weitz Jc.  Detection of fecal Cryptosporidium parvum antigens using an ELISA technique , 1995 .

[83]  P. Fioretti,et al.  Lack of any estrogenic effect of ipriflavone in postmenopausal women , 1992, Journal of endocrinological investigation.

[84]  D. Rathore,et al.  A Rapid Spectrophotometric Method for the Determination of Nitrite in Water. , 1990 .

[85]  A. Tappel,et al.  Purification and properties of rat lung soluble glutathione peroxidase. , 1976, Biochimica et biophysica acta.

[86]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[87]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[88]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[89]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[90]  H. Zalkin,et al.  Inhibition of lipide peroxidation in mitochondria by vitamin E , 1959 .

[91]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[92]  I. Ferrer,et al.  Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease. , 2017, Frontiers in bioscience.

[93]  M. Tabaton,et al.  JNK and ERK 1/2 have a dual opposite effect on the expression of BACE1 , 2009 .

[94]  L. Lue,et al.  Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. , 2008, Neurobiology of disease.

[95]  R. Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid beta peptide. , 2007, Biochimica et biophysica acta.

[96]  W. Markesbery,et al.  Regional Membrane Phospholipid Alterations in Alzheimer's Disease , 2004, Neurochemical Research.

[97]  Wolfgang Schmid,et al.  Disruption of CREB function in brain leads to neurodegeneration , 2002, Nature Genetics.

[98]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[99]  J. C. Weitz.  [Detection of fecal Cryptosporidium parvum antigens using an ELISA technique]. , 1995, Revista medica de Chile.